Patricia D. Williams

Author

Also Known As

P D Williams, P. D. WILLIAMS, P. D. Williams, P.D Williams, P.D. Williams, Patricia D Williams, Patricia D. Williams, Patricia Williams

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Eli Lilly (United States)Bristol-Myers Squibb (Germany)Henry Ford Health System SUNY Upstate Medical University

About

Patricia D. Williams is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	19	832
2	Engineering	1	1	11
3	Health Sciences	1	1	12
4	Nursing	1	1	20
5	Public Health	1	1	20

Patricia D. Williams

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Characterization of renal ischemia-reperfusion injury in rats Patricia D. Williams, Henry Lopez, Deborah Britt, Journal of Pharmacological and Toxicological Methods Renal Ischemia-reperfusion InjuryPhysiologyVascular BiologyRenal PathophysiologyReperfusion Injury	1997	152
Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides. Patricia D. Williams, G. H. Hottendorf, Damien Bennett Journal of Pharmacology and Experimental Therapeutics	1986	84
Correlation between renal membrane binding and nephrotoxicity of aminoglycosides Patricia D. Williams, Damien Bennett, Carol Gleason, Antimicrobial Agents and Chemotherapy Rat Renal CortexRenal FunctionMedicinePhysiologyRenal Membranes	1987	82
Effects of cis-diamminedichloroplatinum(II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Lee K. Tay, Carla L. Bregman, Barbara A. Masters, PubMed UrologyMitochondrial Marker EnzymeRabbit KidneyRenal FunctionRenal Synthetic Activity	1988	66
Animal model for evaluating the convulsive liability of beta-lactam antibiotics Patricia D. Williams, Damien Bennett, C. R. Comereski Antimicrobial Agents and Chemotherapy PharmacotherapyAntimicrobial ChemotherapyDrug ResistanceBeta-lactam AntibioticsInfection Control	1988	57
Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke Patricia D. Williams, Berislav V. Zloković, John H. Griffin, Current Pharmaceutical Design ImmunologyCerebrovascular DiseasePharmacotherapyCerebral Vascular RegulationInflammation	2012	56
Gentamicin nephrotoxicity I. Acute biochemical correlates in rats Patricia D. Williams, P D Holohan, Charles R. Ross Toxicology and Applied Pharmacology Gentamicin NephrotoxicityMedicineToxicologyRenal PathophysiologyPharmacology	1981	54
Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem Ivana P. Day, Joy Goudie, K Nishiki, Toxicology Letters Vivo ModelsAntibioticsMedicineExperimental PharmacologyPharmacotherapy	1995	50
Inhibition of renal Na+, K+-adenosine triphosphatase by gentamicin. Patricia D. Williams, M E Trimble, Laura Marchal–Crespo, Journal of Pharmacology and Experimental Therapeutics	1984	43
Gentamicin nephrotoxicity II. Plasma membrane changes Patricia D. Williams, P D Holohan, Charles R. Ross Toxicology and Applied Pharmacology Renal FunctionGentamicin Nephrotoxicity IiMedicineRenal PathologyPharmacology	1981	40

Page 1